Evidence map›Paper›PMID 39804509›Full record

ArticleEuropean radiology experimental2025

Automated characterisation of cerebral microbleeds using their size and spatial distribution on brain MRI.

Vaanathi Sundaresan, Giovanna Zamboni, Robert A Dineen, Dorothee P Auer, Stamatios N Sotiropoulos, Nikola Sprigg, Mark Jenkinson, Ludovica Griffanti

Abstract read
In one paragraph

Article in European radiology experimental, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Observational
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Vaanathi SundaresanDepartment of Computational and Data Sciences, Indian Institute of Science, Bengaluru, 560012, Karnataka, India.
Giovanna ZamboniNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, OX3 9DU, UK.
Robert A DineenNational Institute for Health and Care Research (NIHR) Nottingham Biomedical Research Centre, Queens Medical Centre, Sir Peter Mansfield Imaging Centre, University of Nottingham, Nottingham, NG7 2RD, UK.
Dorothee P AuerNational Institute for Health and Care Research (NIHR) Nottingham Biomedical Research Centre, Queens Medical Centre, Sir Peter Mansfield Imaging Centre, University of Nottingham, Nottingham, NG7 2RD, UK.
Stamatios N SotiropoulosNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, OX3 9DU, UK.
Nikola SpriggRadiological Sciences, Mental Health and Clinical Neurosciences, School of Medicine, University of Nottingham, Nottingham, NG7 2RD, UK.
Mark Jenkinson *Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, OX3 9DU, UK.
Ludovica Griffanti *Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, OX3 9DU, UK. ludovica.griffanti@psych.ox.ac.uk.ORCID http://orcid.org/0000-0002-0540-9353

Funding

Alzheimer's Association AARF-21-846366British Heart Foundation PG/14/96/31262EPSRC Centre for Doctoral Training in Medical Imaging EP/L016052/1Italian Ministry of Education (MIUR) Dipartimenti di eccellenza 2018-2022NIHR Oxford Health Biomedical Research Centre NIHR203316Pratiksha Trust, Bangalore, India FG/PTCH-23-1004The Wellcome Trust DBT India Alliance IA/E/22/1/506763Wellcome TrustWellcome Trust 203139/Z/16/Z; 203139/A/16/ZWellcome Trust 215573/Z/19/Z
6 · The paper itself

Abstract

Cerebral microbleeds (CMBs) are small, hypointense hemosiderin deposits in the brain measuring 2-10 mm in diameter. As one of the important biomarkers of small vessel disease, they have been associated with various neurodegenerative and cerebrovascular diseases. Hence, automated detection, and subsequent extraction of clinically useful metrics (e.g., size and spatial distribution) from CMBs are essential for investigating their clinical impact, especially in large-scale studies. While some work has been done for CMB segmentation, extraction of clinically relevant information is not yet explored. Herein, we propose the first automated method to characterise CMBs using their size and spatial distribution, i.e., CMB count in three regions (and their substructures) used in Microbleed Anatomical Rating Scale (MARS): infratentorial, deep, and lobar. Our method uses structural atlases of the brain for determining individual regions. On an intracerebral haemorrhage study dataset, we achieved a mean absolute error of 2.5 mm for size estimation and an overall accuracy > 90% for automated rating. The code and the atlas of MARS regions in Montreal Neurological Institute-MNI space are publicly available. RELEVANCE STATEMENT: Our method to automatically characterise cerebral microbleeds (size and location) showed a mean absolute error of 2.5 mm for size estimation and an over 90% accuracy for rating of infratentorial, deep and lobar regions. This is a promising approach to automatically provide clinically relevant cerebral microbleeds metrics. KEY POINTS: We present a method to automatically characterise cerebral microbleeds according to size and location. The method achieved a mean absolute error of 2.5 mm for size estimation. Automated rating for infratentorial, deep, and lobar regions achieved an over 90% overall accuracy. We made the code and atlas of Microbleed Anatomical Rating Scale regions publicly available.

Indexed as

Cerebral HemorrhageImage Interpretation, Computer-AssistedMagnetic Resonance ImagingAgedBrainFemaleHumansMaleBrainCerebral haemorrhageCerebrovascular disordersHemosiderinMagnetic resonance imaging

Identifiers

PMID39804509
PMCPMC11730040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.